+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Third type serotonin receptor blockers (5-HT-3) as a new class of antiemetic drugs



Third type serotonin receptor blockers (5-HT-3) as a new class of antiemetic drugs



Eksperimental'naya i Klinicheskaya Farmakologiya 57(4): 72-75



Data from the literature on the antiemetic activity of pharmacological agents blocking the third type serotonin receptors are considered.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 009643176

Download citation: RISBibTeXText


Related references

Type-3 serotonin receptor blockaders (5-HT3)--a new class of antiemetic preparations. Eksperimental'naia i Klinicheskaia Farmakologiia 57(4): 72-75, 1994

Randomized comparison of the antiemetic efficacy of a serotonin type 3 receptor antagonist (MDL 72,222) with a high-dose metoclopramide regimen. American Journal of Clinical Oncology 16(2): 175-179, 1993

Angiotensin II receptor blockers. A new class of antihypertensive drugs. Archives of Family Medicine 5(6): 351-356, 1996

Effect of ginseng saponins on the recombinant serotonin type 3A receptor expressed in xenopus oocytes: implication of possible application as an antiemetic. Journal of Alternative and Complementary Medicine 9(4): 505-510, 2003

Correlations between different measures of antiserotonin activity of drugs. Study with neuroleptics and serotonin receptor blockers. Naunyn-Schmiedeberg's Archives of Pharmacology 321(4): 265-270, 1982

Serotonin antagonists: a new class of antiemetic agents. Journal of the National Cancer Institute 83(9): 613-620, 1991

Nondepolarizing neuromuscular blockers inhibit the serotonin-type 3A receptor expressed in Xenopus oocytes. Anesthesia and Analgesia 90(2): 476-481, 2000

Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316(6024): 126-131, 1985

Class- and molecule-specific differential effects of angiotensin II type 1 receptor blockers. Current Pharmaceutical Design 19(17): 3002-3008, 2013

Identifying patterns of adverse event reporting for four members of the angiotensin II receptor blockers class of drugs: revisiting the Weber effect. Pharmacoepidemiology and Drug Safety 17(9): 882-889, 2008

Differential antiarrhythmic atrial selective actions of novel IKur- versus IKr-, IKs-, IKAch-blockers, class Ic drugs and beta-blockers in pigs. European Heart Journal 24(Abstract Supplement): 721, August-September, 2003

Broad-spectrum antiemetic potential of the L-type calcium channel antagonist nifedipine and evidence for its additive antiemetic interaction with the 5-HT(3) receptor antagonist palonosetron in the least shrew (Cryptotis parva). European Journal of Pharmacology 722: 2-12, 2014

Comparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetes. Cardiovascular Diabetology 11: 53, 2012

Antiemetic effects of ad 5370 a novel serotonin 5 ht 3 receptor antagonists. European Journal of Pharmacology 183(4): 1214-1215, 1990

Evaluation of the serotonin receptor blockers ketanserin and methiothepin on the pulmonary hypertensive responses (if broilers to intravenously infused serotonin. Poultry Science 85: 41-41, 2006